Jack H. Dean - Jan 6, 2025 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
Director
Signature
/s/ Kostantinos Skordalos, Power of Attorney For: Jack H. Dean
Stock symbol
ACXP
Transactions as of
Jan 6, 2025
Transactions value $
$10,000
Form type
4
Date filed
1/8/2025, 04:30 PM
Previous filing
Jun 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACXP Common Stock Purchase $10K +9.85K +82.62% $1.02 21.8K Jan 6, 2025 Direct F1
holding ACXP Common Stock 5.77K Jan 6, 2025 By Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACXP Warrants for Common Stock Purchase $0 +9.85K $0.00 9.85K Jan 6, 2025 Common Stock 9.85K $0.90 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc.
F2 Shares held by the Dean Family Trust. The reporting person is the Trustee of the Dean Family Trust.
F3 Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock.